Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Advances in CAR T-Cell Therapy for Aggressive B-NHL.
Growth arrest- and DNA-damage-inducible 45beta gene inhibits c-Jun N-terminal kinase and extracellular signal-regulated kinase and decreases IL-1beta-induced apoptosis in insulin-producing INS-1E cells.
Leflunomide, a novel immunomodulatory agent: in vitro analyses of the mechanism of immunosuppression.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Advances in CAR T-Cell Therapy for Aggressive B-NHL.
Advances in CAR T-Cell Therapy for Aggressive B-NHL. Clin Lymphoma Myeloma Leuk. 2020 09; 20 Suppl 1:S94-S97.
View in:
PubMed
subject areas
Humans
Immunotherapy, Adoptive
Lymphoma, Non-Hodgkin
authors with profiles
Peter Riedell